← Back to Search

Unknown

MYK-224 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 130 days
Awards & highlights

Study Summary

This trial will study the effects of MYK-224, given either as a single dose or multiple doses, on healthy adult Japanese participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 130 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 130 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration (AUC[0-T])
Maximum observed plasma concentration (Cmax)
Time of maximum observed concentration (Tmax)
Secondary outcome measures
Measurement of LV end diastolic volume
Measurement of LV end diastolic volume index
Measurement of LV end systolic volume
+23 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Arm 4Experimental Treatment2 Interventions
Group II: Arm 3Experimental Treatment2 Interventions
Group III: Arm 2Experimental Treatment2 Interventions
Group IV: Arm 1Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MYK-224
2023
Completed Phase 1
~90

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,638 Previous Clinical Trials
4,128,478 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available to join this clinical trial?

"Indeed, information hosted on clinicaltrials.gov reveals that this medical trial is actively trying to find participants. It was first made public on July 12th 2022 and the latest update was posted September 15th that same year. A total of 36 people need to be enrolled at one site."

Answered by AI

How many participants is the trial currently accommodating?

"Absolutely. According to clinicaltrials.gov, this experiment is still recruiting participants from a single location. It was initially posted on July 12th 2022 and the most recent update came on September 15th of that year; 36 patients need to be enrolled in total."

Answered by AI

How can I gain access to this investigation?

"For inclusion in this research, volunteers must be hale and hearty between 18-60 years old. There are 36 positions available for qualified candidates."

Answered by AI

Can adults aged 18 and over partake in this trial?

"The eligibility requirements for this trial stipulate that enrollees must be aged 18 or over and no older than sixty years of age."

Answered by AI

Has MYK-224 earned the endorsement of the Food and Drug Administration?

"MYK-224's safety rating on a scale of 1 to 3 is estimated at 1 due to the limited data that has been obtained in Phase 1 trials, which implies minimal evidence for both efficacy and safety."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Local Institution
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants
2022. "A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05405543.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top